Stock Market

Story: Winklevoss-Backed Cypherpunk Holds 323,394 ZEC While Chasing Cancer Drug Trials

By Maheen Hernandez

1 / 15

Shares Down 96% Over Five Years. Cypherpunk shares peaked at $3.70 last November. They've since collapsed to below $0.69.

2 / 15

Sirexatamab's Rocky Path to Phase 3. The cancer drug push centers on Sirexatamab, an anti-DKK1 antibody.

3 / 15

What the Funding Gap Actually Means. The accumulated deficit situation is serious. Cypherpunk is actively looking for external capital…

4 / 15

Cypherpunk Technologies is making a hard pivot. The Winklevoss-backed company, sitting on a massive Zcash treasury, just posted a $37.

5 / 15

The numbers are pretty rough. Cypherpunk holds 323,394 ZEC, which works out to roughly $157 million in crypto assets.

6 / 15

Cypherpunk shares peaked at $3.70 last November. They've since collapsed to below $0.69. That's a 96% drop over five years — brutal by any measure.

7 / 15

The crypto side of the business isn't exactly firing either. Zcash has been basically flat over the year, so Cypherpunk can't count on ZEC appreciation to bail it out.

8 / 15

And there's the Gemini connection. Cameron and Tyler Winklevoss control Gemini, the exchange that serves as custodian for Cypherpunk's Zcash holdings.

9 / 15

The cancer drug push centers on Sirexatamab, an anti-DKK1 antibody. It didn't outperform the control group in its Phase 2 study — specifically, it failed to show a meaningful…

10 / 15

See also: US Inflation Holds at 3.4% While Bitcoin Traders Watch Feds Next Move

11 / 15

That trial costs money Cypherpunk doesn't obviously have sitting around. The company is weighing its options — either funding the Phase 3 independently through some kind of…

12 / 15

The Phase 2 miss is the awkward fact hanging over all of this. Drug development is brutal even when Phase 2 works.

13 / 15

So the company is essentially running two capital-intensive strategies at once. It wants to keep accumulating Zcash toward that 5% target.

14 / 15

The accumulated deficit situation is serious. Cypherpunk is actively looking for external capital — potential collaborations on the pharma side, possibly other structures.

15 / 15

See also: Binance Holds Firm in Singapore Court Fight Over $473 Million RedotPay Claim

The Currency Analytics

Want the full story?